Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 4Phase 3 2Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Other solid neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Solid Tumors 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1

Interventions

pembrolizumab 109Paclitaxel 65Cyclophosphamide 65Cisplatin 60Carboplatin 56Gemcitabine 48Radiotherapy 45Nivolumab 44fludarabine 38Docetaxel 38Pemetrexed 33Dexamethasone 32Capecitabine 32Lenalidomide 26fludarabine phosphate 25Rituximab 25Radiation 25Ipilimumab 25Doxorubicin 25Irinotecan 24Bevacizumab 24Azacitidine 24Vorinostat 23Vincristine 22Cytarabine 22Temozolomide 20Etoposide 20Oxaliplatin 19Fluorouracil 19atezolizumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Has results × glasdegib × Clear all
NCT02038777 2025-02-26

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Pfizer

Phase 1 Completed
48 enrolled 85 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00953758 2024-04-25

A Study Of PF-04449913 In Select Hematologic Malignancies

Pfizer

Phase 1 Completed
47 enrolled 45 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT01286467 2024-03-06

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Pfizer

Phase 1 Completed
23 enrolled 26 charts
Other solid neoplasm

Solid Tumors

NCT02367456 2024-01-19

BRIGHT 1012

Pfizer

Phase 1 Completed
73 enrolled 31 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡